Method for forming a tissue construct and use thereof

Patent metadata

Field	Value
Publication number	US-9861465-B2
Application number	US-201113825540-A
Country	US
Kind code	B2
Filing date	Sep 22, 2011
Priority date	Sep 22, 2010
Publication date	Jan 9, 2018
Grant date	Jan 9, 2018

Abstract

The present invention relates to a method for forming a tissue construct having a composite structure. The method includes providing a biodegradable substrate, wherein the substrate is adapted to allow deposition or growth of a plurality of cells; providing a vascularized layer comprising a plurality of blood vessels therein; and adhering the vascularized layer to the substrate.

First claim

The invention claimed is:

1. An in vitro method for forming a tissue construct having a composite structure, comprising:
(a) providing a biodegradable substrate in vitro, wherein the substrate is adapted to allow deposition or growth of a plurality of cells;
(b) providing a vascularized layer in vitro, the vascularized layer comprising a plurality of blood vessels therein; and
(c) adhering the vascularized layer to the biodegradable substrate in vitro.

2. The in vitro method of claim 1 , wherein the plurality of blood vessels are formed by:
(i) providing a plurality of biodegradable fibres;
(ii) encapsulating the plurality of biodegradable fibres with cells selected from the group consisting of endothelial cells, smooth muscle cells, microvascular endothelial cells, stem cells, and combination thereof; and
(iii) allowing the biodegradable fibres to degrade.

3. The in vitro method of claim 2 , further comprising embedding the plurality of biodegradable fibers encapsulated with cells in a gel.

4. The in vitro method of claim 2 , wherein encapsulating comprises culturing the biodegradable fibres with the cells in the presence of growth factors such as vascular endothelial growth factor (VEGF) medium.

5. The in vitro method of claim 2 , wherein each of the substrate and the biodegradable fibres is independently selected from the group consisting of a polyglycolide, a polylactide, a polycaprolactone, a polyamide, an aliphatic polyester, a poly(ester amide), a poly(amino acid), a pseudo-poly(amino acid), a poly(lactide glycolide), poly(lactic acid ethylene glycol), poly(ethylene glycol), poly(ethylene glycol) diacrylate, a polyalkylene succinate, polybutylene diglycolate, polyhydroxybutyrate, polyhydroxyvalerate, a polyhydroxy-butyrate/polyhydroxyvalerate copolymer, poly(hydroxybutyrate-co-valerate), a polyhydroxyalkaoates, a poly(caprolactone-polyethylene glycol) copolymer, poly(valerolactone), a polyanhydride, a poly(orthoester), a polyanhydride, a polyanhydride ester, poly(anhydride-co-imide), an aliphatic polycarbonate, a poly(hydroxyl-ester), a polydioxanone, a polycyanoacrylate, a poly(alkyl cyanoacrylate), a poly(amino acid), a poly(phosphazene), a poly-(propylene fumarate), poly(propylene fumarate-co-ethylene glycol), a poly(fumarate anhydride), a poly(propylene carbonate), fibrinogen, fibrin, gelatin, cellulose, a cellulose derivative, chitosan, alginate, a polysaccharide, starch, amylase, collagen, a polycarboxylic acid, a poly(ethyl ester-co-carboxylate carbonate), poly(iminocarbonate), poly(bisphenol A-iminocarbonate), poly(trimethylene carbonate), poly(ethylene oxide), poly(epsilon-caprolactone-dimethyltrimethylene carbonate), a poly(alkylene oxalate), a poly(alkylcarbonate), poly(adipic anhydride), a nylon copolyamide, carboxymethyl cellulose, a copoly(ether-ester), a polyether, a polyester, a polydihydropyran, a polyketal, a polydepsipeptide, a polyarylate, a poly(propylene fumarate-co-ethylene glycol), a hyaluronates, poly-p-dioxanone, a polyphosphoester, a polyphosphoester urethane, rayon, rayon triacetate, latex, and a composite thereof.

6. The in vitro method of claim 5 , wherein the biodegradable fibres are poly(lactic-co-glycolic acid) (PLGA).

7. The in vitro method of claim 1 , wherein the surface of the substrate is patterned to form a plurality of regions for the deposition or growth of the plurality of cells thereon.

8. The in vitro method of claim 7 , wherein the substrate is further patterned to form a plurality of channels in the direction transverse to the substrate surface.

9. The in vitro method of claim 7 , wherein the patterning of the substrate surface is formed by micro-contact printing, laser cutting, lithography or fibre spinning.

10. The in vitro method of claim 1 , wherein the adhering comprises adhering the vascularized layer to the substrate via an intermediate layer.

11. The in vitro method of claim 10 , wherein the intermediate layer is formed of gelatin, collagen or fibrin glue.

12. The in vitro method of claim 1 , wherein the adhering comprises suturing the vascularized layer to the substrate.

13. A method, comprising:
using an in vitro tissue construct having a composite structure that includes:
(a) a biodegradable substrate adapted to allow deposition or growth of a plurality of cells; and
(b) a vascularized layer comprising a plurality of blood vessels therein, wherein the using includes growing and structuring new tissue using the tissue construct or repairing damaged tissue using the tissue construct, wherein the vascularized layer is adhered to the biodegradable substrate.

Assignees

• Tan Lay Poh
• Wong Philip
• Boey Yin Chiang Freddy
• Venkatraman Subbu
• Univ Nanyang Tech

Inventors

• Tan Lay Poh
• Wong Philip
• Boey Yin Chiang Freddy
• Venkatraman Subbu

Classifications

• A61L27/54

  Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

• A61L27/3808 Primary

  Endothelial cells · CPC title

• A61L27/507

  for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062) · CPC title

• A61L27/3826

  Muscle cells, e.g. smooth muscle cells · CPC title

• C08L67/04

  Polyesters derived from hydroxycarboxylic acids, e.g. lactones (C08L67/06 takes precedence) · CPC title